Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Daiki Kato
Person

Daiki Kato

Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Aug 24, 2026

Sentiment
5
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 5
Business
Anbogen and University of Tokyo Collaborate on ABT-301
AnBogen Therapeutics Inc. (TPEx: 7784), a Taiwan-based clinical-stage precision oncology company, announced on August 24, 2026 that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduate School of…
Impact: Daiki Kato is a lead researcher from the University of Tokyo who will lead the collaborative research, contributing to the scientific evaluation of ABT-301.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Daiki Kato live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.